comparemela.com

Latest Breaking News On - Sectoral asset management inc - Page 1 : comparemela.com

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Bought by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC lifted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 65.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 4,222,222 shares of the company’s stock after acquiring an additional 1,666,667 shares during the quarter. Syndax Pharmaceuticals comprises approximately 1.3% of Avoro Capital Advisors LLC’s portfolio, making […]

Stifel-nicolaus
Rafferty-asset-management
Axiom-investors
Holdings-channel
Quarter-for-syndax-pharmaceuticals
Syndax-pharmaceuticals
Citigroup
Syndax-pharmaceuticals-inc
Sectoral-asset-management-inc
Avoro-capital-advisors
Nasdaq
News-ratings-for-syndax-pharmaceuticals-daily

Avoro Capital Advisors LLC Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)

Avoro Capital Advisors LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 2,858,888 shares of the biotechnology company’s stock after purchasing an additional 6,388 shares during the quarter. United Therapeutics comprises approximately 8.7% of Avoro Capital Advisors LLC’s […]

United-states
Martinea-rothblatt
Schroder-investment-management-group
Securities-exchange-commission
Holdings-channel
Nasdaq
Epoch-investment-partners-inc
United-therapeutics-corporation
United-therapeutics-co
Vinva-investment-management-ltd
Sectoral-asset-management-inc

Personal CFO Solutions LLC Has $1.71 Million Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

Personal CFO Solutions LLC boosted its position in shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Free Report) by 57.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 550,342 shares of the company’s stock after purchasing an additional 200,000 shares during the period. Personal CFO […]

Craig-hallum
Alkeon-capital-management
Nasdaq
Jefferies-financial-group
Securities-exchange-commission
Barclays-plc
Euclidean-capital
Pharmaceuticals-daily
Sectoral-asset-management-inc
Pharmaceuticals-stock-performance
Pharmaceuticals-inc
Vontobel-holding-ltd

Sectoral Asset Management Inc. Sells 167,240 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Sectoral Asset Management Inc. cut its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 92.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,955 shares of the company’s stock after selling 167,240 shares during the quarter. Sectoral […]

Randalw-scott
Bio-pharma
Jpmorgan-chase-co
Boone-capital-management
Bio-pharma-inc
Manufacturers-life-insurance-company
Nasdaq
Campbell-co-investment-adviser
Securities-exchange-commission
Sectoral-asset-management-inc
Cantor-fitzgerald

Sectoral Asset Management Inc. Has $531,000 Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)

Sectoral Asset Management Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 94.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,420 shares of the biopharmaceutical company’s stock after selling 116,260 shares during the period. Sectoral Asset Management Inc.’s holdings […]

United-states
Canada
Michael-halstead
Norges-bank
Cantor-fitzgerald
Cellular-therapies-company-profile
Sectoral-asset-management-inc
Goldman-sachs-group
Nasdaq
Canaccord-genuity-group
Cellular-therapies-inc
Royal-bank

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.